Фармакоэкономика, 2015 Currently, chronic obstructive pulmonary disease (COPD) is a 5-largest cause of death worldwide, and the reduced activities of daily living, productivity and disability explain a significant economic and social damage.
A. U. Kulikov, I. A. Komarov
doaj
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
International Journal of COPD, 2012 Roland Buhl,1 Donald Banerji21Pulmonary Department, Mainz University Hospital, Mainz, Germany; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAAbstract: Bronchodilators are central in the symptomatic management of chronic obstructive ...
Buhl R, Banerji D
doaj
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol. [PDF]
Int J Chron Obstruct Pulmon Dis, 2019 Moretz C +8 more
europepmc +1 more source
Effect of different doses of Budesonide combined with Tiotropium bromide inhalation on elderly patients with chronic obstructive pulmonary disease. [PDF]
Pak J Med SciYu J, Ni J, Chen X, Fang Y, Fu S.
europepmc +1 more source
Effects of co-application of tiotropium bromide and traditional Chinese medicine on patients with stable chronic obstructive pulmonary disease: a muilticenter, randomized, controlled trial study. [PDF]
Front Med (Lausanne)Chen R +7 more
europepmc +1 more source
A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use [PDF]
, 2016 core +1 more source
The evidence on tiotropium bromide in asthma: from the rationale to the bedside. [PDF]
Multidiscip Respir Med, 2017 Radovanovic D +3 more
europepmc +1 more source
Mometasone or tiotropium in mild asthma with a low sputum eosinophil level [PDF]
, 2019 Bacharier, Leonard B., Castro, Mario
core +1 more source